These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8645429)

  • 1. Effects of mutationally activated Ha-ras on c-fos expression kinetics in rat tracheal epithelial cells.
    Hubbard FC; Cosma G; Garte SJ
    Mol Carcinog; 1996 Jun; 16(2):77-82. PubMed ID: 8645429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells.
    Johnson TA; Li J; Beer DG
    Mol Carcinog; 1996 Oct; 17(2):70-7. PubMed ID: 8890955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of myeloid cell growth by distinct effectors of Ras.
    Matsuguchi T; Kraft AS
    Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation.
    Barr LF; Mabry M; Nelkin BD; Tyler G; May WS; Baylin SB
    Cancer Res; 1991 Oct; 51(20):5514-9. PubMed ID: 1655253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late responses to induction of rasT24 expression in Rat-1 cells.
    Godwin AK; Lieberman MW
    Oncogene; 1990 Aug; 5(8):1231-41. PubMed ID: 2202952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
    Farrell RE; Greene JJ
    J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
    Xu Y; Deng GR; Liang YY; Li C
    Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha.
    Chang MY; Won SJ; Yang BC; Jan MS; Liu HS
    Exp Cell Res; 1999 May; 248(2):589-98. PubMed ID: 10222151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anisomycin abrogates repression of protooncogene c-fos transcription in E1A + cHa-ras-transformed cells through activation of MEK/ERK kinase cascade.
    Kukushkin AN; Svetlikova SB; Amanzholov RA; Pospelov VA
    J Cell Biochem; 2008 Feb; 103(3):1005-12. PubMed ID: 17647273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
    Wisdom R; Huynh L; Hsia D; Kim S
    Oncogene; 2005 Oct; 24(47):7043-54. PubMed ID: 16007133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
    Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
    Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MNU-induced point mutation and activation of c-Ha-ras oncogene in cell lines derived from human pancreas explants.
    Maheshwari KK; Parsa I; Marsh WH
    Biochem Int; 1990; 20(1):117-25. PubMed ID: 2183801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
    Fernandes ER; Ashendel CL
    Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of rat bladder epithelial cells by introduction of a single oncogene.
    Mann AM; Stevenson M; Masui T; Borgeson CD; Cohen SM
    Oncogene Res; 1991; 6(1):65-72. PubMed ID: 1847743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the TCF phosphorylation state and the chromatin structure in the negative transcription regulation of the c-fos proto-oncogene in E1A + c-Ha-ras transformed cells].
    Abramova MV; Kukushkin AN; Pospelova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2002; 36(1):66-75. PubMed ID: 11862715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
    Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human trithorax protein hASH2 functions as an oncoprotein.
    Lüscher-Firzlaff J; Gawlista I; Vervoorts J; Kapelle K; Braunschweig T; Walsemann G; Rodgarkia-Schamberger C; Schuchlautz H; Dreschers S; Kremmer E; Lilischkis R; Cerni C; Wellmann A; Lüscher B
    Cancer Res; 2008 Feb; 68(3):749-58. PubMed ID: 18245475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.